MMP9 and Hyperglycemia: What is known so far is that hyperglycemia is known to induce oxidative stress and ROS production in vivo, which are able to inhibit the proliferation and the function of EPCs concomitant with the reduction of NO synthesis and matrix metalloproteinase 9 (MMP-9), which are necessary for the mobilization of these cells by the bone marrow [48].